Amoxycillin 600mg + Potassium Clavulanate 42.9mg Dry Syrup in PCD pharma franchise in Hyderabad

Amoxycillin 600mg + Potassium Clavulanate 42.9mg Dry Syrup in pharmaceutical manufacturing company in Mumbai

Amoxycillin 600mg + Potassium Clavulanate 42.9mg Dry Syrup in antibiotic pharma franchise in Pune

Amoxycillin 600mg + Potassium Clavulanate 42.9mg Dry Syrup in pharma suppliers in Delhi

Amoxycillin 600mg + Potassium Clavulanate 42.9mg Dry Syrup in pharma export companies in Kolkata
Amoxycillin 600mg + Potassium Clavulanate 42.9mg Dry Syrup in pharma franchise opportunities in Bengaluru

Home/Products /amoxycillin-potassium-clavulanate-mg-dry-syrup

About the Product

Description


Moxyplit ES Dry Syrup is a pediatric oral formulation combining Amoxycillin (600mg), a broad-spectrum penicillin antibiotic, with Potassium Clavulanate (42.9mg), a β-lactamase inhibitor. This powerful combination enhances the efficacy of amoxycillin by protecting it from degradation by β-lactamase-producing bacteria. The syrup is effective against a wide range of bacterial infections commonly affecting children, including respiratory tract infections, otitis media, sinusitis, and urinary tract infections. The extended-spectrum (ES) formulation ensures potent antibacterial action with convenient dosing for better compliance in pediatric care.

Common side effects may include diarrhea, nausea, vomiting, or mild skin rash. Some children may experience abdominal discomfort or allergic reactions. Severe allergic responses or persistent gastrointestinal symptoms should be promptly reported to a doctor.

Moxyplit ES Dry Syrup is indicated for the treatment of pediatric bacterial infections, such as acute otitis media, sinusitis, pneumonia, bronchitis, tonsillitis, and urinary tract infections, especially when caused by β-lactamase-producing strains resistant to amoxycillin alone.

This medication should be used only under the supervision of a pediatrician. Complete the prescribed course even if symptoms improve early. Shake well before each use. Not effective against viral infections. Reconstitution instructions must be followed carefully.

Store the dry syrup bottle in a cool, dry place below 25°C, away from sunlight. After reconstitution with boiled and cooled water, keep refrigerated (2°C to 8°C) and use within 7 days. Discard any remaining syrup after this period. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Amoxycillin + Potassium Clavulanate Dry Syrup in the PCD pharma franchise market?

This pediatric antibiotic dry syrup has strong demand in the anti-infective and child healthcare segment, making it a high-moving product for medical distributors, wholesalers, and pharma franchise partners focusing on pediatric and general medicine portfolios.

Why should medical distributors include this dry syrup in their product range?

Medical distributors and agencies can benefit from consistent demand for treatment of respiratory tract infections, ear infections, throat infections, sinus infections, urinary tract infections, and other bacterial infections in children. Amoxycillin helps eliminate infection-causing bacteria, while Potassium Clavulanate enhances antibiotic effectiveness by overcoming bacterial resistance, strengthening a reliable pediatric antibiotic product portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for this pediatric antibiotic dry syrup with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from strong pediatric prescription demand, fast-moving anti-infective category, seasonal infection sales growth, reliable supply chain support, and good margins when partnering for this pediatric antibiotic product.

How can I become a distributor or franchise partner for this dry syrup?

Medical distributors, stockists, and wholesalers interested in this pediatric antibiotic dry syrup can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.